| Multisystem inflammatory syndrome in US children and adolescents LR Feldstein, EB Rose, SM Horwitz, JP Collins, MM Newhams, MBF Son, ... New England Journal of Medicine 383 (4), 334-346, 2020 | 2927 | 2020 |
| Characteristics and outcomes of US children and adolescents with multisystem inflammatory syndrome in children (MIS-C) compared with severe acute COVID-19 LR Feldstein, MW Tenforde, KG Friedman, M Newhams, EB Rose, ... Jama 325 (11), 1074-1087, 2021 | 930 | 2021 |
| Neurologic involvement in children and adolescents hospitalized in the United States for COVID-19 or multisystem inflammatory syndrome KL LaRovere, BJ Riggs, TY Poussaint, CC Young, MM Newhams, ... JAMA neurology 78 (5), 536-547, 2021 | 434 | 2021 |
| Multisystem inflammatory syndrome in children—initial therapy and outcomes MBF Son, N Murray, K Friedman, CC Young, MM Newhams, LR Feldstein, ... New England Journal of Medicine 385 (1), 23-34, 2021 | 388 | 2021 |
| Paediatric acute respiratory distress syndrome incidence and epidemiology (PARDIE): an international, observational study RG Khemani, L Smith, YM Lopez-Fernandez, J Kwok, R Morzov, MJ Klein, ... The Lancet Respiratory Medicine 7 (2), 115-128, 2019 | 328 | 2019 |
| Effectiveness of BNT162b2 (Pfizer-BioNTech) mRNA vaccination against multisystem inflammatory syndrome in children among persons aged 12–18 years—United States, July–December 2021 LD Zambrano MMWR. Morbidity and mortality weekly report 71, 2022 | 318 | 2022 |
| BNT162b2 protection against the omicron variant in children and adolescents AM Price, SM Olson, MM Newhams, NB Halasa, JA Boom, LC Sahni, ... New England Journal of Medicine 386 (20), 1899-1909, 2022 | 264 | 2022 |
| Effectiveness of BNT162b2 vaccine against critical Covid-19 in adolescents SM Olson, MM Newhams, NB Halasa, AM Price, JA Boom, LC Sahni, ... New England Journal of Medicine 386 (8), 713-723, 2022 | 213 | 2022 |
| Effectiveness of maternal vaccination with mRNA COVID-19 vaccine during pregnancy against COVID-19–associated hospitalization in infants aged 6 Months—17 states, july 2021 … NB Halasa MMWR. Morbidity and mortality weekly report 71, 2022 | 203 | 2022 |
| Maternal vaccination and risk of hospitalization for Covid-19 among infants NB Halasa, SM Olson, MA Staat, MM Newhams, AM Price, PS Pannaraj, ... New England Journal of Medicine 387 (2), 109-119, 2022 | 198 | 2022 |
| Effectiveness of Pfizer-BioNTech mRNA vaccination against COVID-19 hospitalization among persons aged 12–18 years—United States, June–September 2021 SM Olson MMWR. Morbidity and mortality weekly report 70, 2021 | 130 | 2021 |
| Executive summary of the second international guidelines for the diagnosis and management of pediatric acute respiratory distress syndrome (PALICC-2) G Emeriaud, YM López-Fernández, NP Iyer, MM Bembea, A Agulnik, ... Pediatric critical care medicine 24 (2), 143-168, 2023 | 116 | 2023 |
| A core outcome set for pediatric critical care EL Fink, AB Maddux, N Pinto, S Sorenson, D Notterman, JM Dean, ... Critical care medicine 48 (12), 1819-1828, 2020 | 101 | 2020 |
| Is the developmentally immature immune response in paediatric sepsis a recapitulation of immune tolerance? AB Maddux, IS Douglas Immunology 145 (1), 1-10, 2015 | 71 | 2015 |
| Second Pediatric Acute Lung Injury Consensus Conference (PALICC-2) Group on behalf of the Pediatric Acute Lung Injury and Sepsis Investigators (PALISI) Network: Executive … G Emeriaud, YM López-Fernández, NP Iyer, MM Bembea, A Agulnik, ... Pediatr Crit Care Med 24 (2), 143-168, 2023 | 70 | 2023 |
| Postdischarge outcome domains in pediatric critical care and the instruments used to evaluate them: a scoping review AB Maddux, N Pinto, EL Fink, ME Hartman, S Nett, K Biagas, EY Killien, ... Critical care medicine 48 (12), e1313-e1321, 2020 | 60 | 2020 |
| Overcoming COVID-19 Investigators: Characteristics and outcomes of US children and adolescents with multisystem inflammatory syndrome in children (MIS-C) compared with severe … LR Feldstein, MW Tenforde, KG Friedman, M Newhams, EB Rose, ... JAMA 325 (11), 1074-1087, 2021 | 57 | 2021 |
| Cross-reactive immunity against the SARS-CoV-2 Omicron variant is low in pediatric patients with prior COVID-19 or MIS-C J Tang, T Novak, J Hecker, G Grubbs, FT Zahra, L Bellusci, ... Nature communications 13 (1), 2979, 2022 | 49 | 2022 |
| Frequency, characteristics and complications of COVID-19 in hospitalized infants CV Hobbs, K Woodworth, CC Young, AM Jackson, MM Newhams, ... The Pediatric infectious disease journal 41 (3), e81-e86, 2022 | 49 | 2022 |
| Vaccine effectiveness against life-threatening influenza illness in US children SM Olson, MM Newhams, NB Halasa, LR Feldstein, T Novak, SL Weiss, ... Clinical Infectious Diseases 75 (2), 230-238, 2022 | 48 | 2022 |
